Celltrion Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CELLTRION, and what generic and branded alternatives to CELLTRION drugs are available?
CELLTRION has four approved drugs.
Summary for Celltrion
US Patents: | 0 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 4 |
PTAB Cases with Celltrion as petitioner: | See PTAB cases with Celltrion as petitioner |
Drugs and US Patents for Celltrion
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | RISPERIDONE | risperidone | TABLET;ORAL | 078871-006 | Oct 9, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Celltrion | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 090367-003 | Jun 20, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Celltrion | LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 090367-002 | Jun 20, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.